Brief: Initiator Pharma Reports Final Analysis Of Positive Efficacy Data From IPTN2021 Program Phase I Study

Initiator Pharma A/S

21/09/2022 08:00

Sept 21 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * REPORTS FINAL ANALYSIS OF POSITIVE EFFICACY DATA FROM
IPTN2021
PROGRAM PHASE I STUDY
    * FINAL ANALYSIS CONFIRMS STATISTICALLY SIGNIFICANT EFFECTS
ON
PAIN MEASURES THAT WERE OBSERVED IN ANALYSIS OF FIRST DATA
READ-OUT FROM STUDY PRESENTED IN MAY 2022

Source text for Eikon:  ID:nMFN89SDJF 
Further company coverage:  INIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))